The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer - PubMed (original) (raw)
The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer
Clarence T Sasaki et al. Oral Oncol. 2020 Jun.
Abstract
Background: Prognosis for hypopharyngeal cancer is usually poor, and recurrence is common. Identifying new factors or related mechanisms that promote its progression may have clinical implications. Although, recent studies support bile reflux in hypopharyngeal carcinogenesis, it remains to be explored how bile and its related NF-κB activated pathway may further affects its progression in already established hypopharyngeal cancer.
Methods: Hypopharyngeal squamous cell carcinoma (HSCC) cell lines, FaDu and UMSCC11A, both negative for HPV, were repetitively exposed to bile acids (400 μM) at variable pH points (4.0, 5.5 and 7.0). Immunofluorescence, western blotting, luciferase assay, and qPCR were used to detect NF-κB activation, bcl-2 overexpression and gene expression.
Results: Bile at strongly acidic pH (4.0) potentiated the activation of NF-κB and its related mRNA phenotype in HSCC cells. IL-6, TNF-α, and BCL2 were found among the highest overexpressed genes as was previously found in HSCCs excised from patients with documented biliary reflux. An enhanced transcriptional activity of EGFR, RELA, STAT3, and WNT5Α and higher survival rates were observed in HSCC cells exposed to acidic bile compared to those exposed to bile at weakly acidic or neutral pH.
Conclusion: Our novel findings support the observation that bile reflux has the potential for actively influencing the progression of hypopharyngeal cancer, mediated by NF-κB. In patients with hypopharyngeal cancer and known gastroesophageal reflux disease, antacid therapy may exert a role in furthering control of disease recurrence and progression.
Keywords: Bile acids; Gastroesophageal reflux; Hypopharyngeal cancer; IL6; Laryngopharyngeal reflux; NF-κB; TNF-α.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors whose names are listed in this article certify that they have NO affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.
Similar articles
- Bile reflux and hypopharyngeal cancer (Review).
Vageli DP, Doukas SG, Doukas PG, Judson BL. Vageli DP, et al. Oncol Rep. 2021 Nov;46(5):244. doi: 10.3892/or.2021.8195. Epub 2021 Sep 24. Oncol Rep. 2021. PMID: 34558652 Free PMC article. Review. - Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
Sasaki CT, Doukas SG, Costa J, Vageli DP. Sasaki CT, et al. Cancer. 2019 Oct 15;125(20):3554-3565. doi: 10.1002/cncr.32369. Epub 2019 Jul 16. Cancer. 2019. PMID: 31310330 - Curcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells.
Vageli DP, Doukas SG, Spock T, Sasaki CT. Vageli DP, et al. J Cell Mol Med. 2018 Sep;22(9):4209-4220. doi: 10.1111/jcmm.13701. Epub 2018 Jun 17. J Cell Mol Med. 2018. PMID: 29911313 Free PMC article. - The In Vitro Effect of Acidic-Pepsin on Nuclear Factor KappaB Activation and Its Related Oncogenic Effect on Normal Human Hypopharyngeal Cells.
Sasaki CT, Toman J, Vageli D. Sasaki CT, et al. PLoS One. 2016 Dec 14;11(12):e0168269. doi: 10.1371/journal.pone.0168269. eCollection 2016. PLoS One. 2016. PMID: 27973541 Free PMC article. - Pepsin and Laryngeal and Hypopharyngeal Carcinomas.
Yin CY, Zhang SS, Zhong JT, Zhou SH. Yin CY, et al. Clin Exp Otorhinolaryngol. 2021 May;14(2):159-168. doi: 10.21053/ceo.2020.00465. Epub 2020 Jul 24. Clin Exp Otorhinolaryngol. 2021. PMID: 32734742 Free PMC article. Review.
Cited by
- Targeting STAT3 prevents bile reflux-induced oncogenic molecular events linked to hypopharyngeal carcinogenesis.
Vageli DP, Doukas PG, Siametis A, Judson BL. Vageli DP, et al. J Cell Mol Med. 2022 Jan;26(1):75-87. doi: 10.1111/jcmm.17011. Epub 2021 Dec 1. J Cell Mol Med. 2022. PMID: 34850540 Free PMC article. - Bile reflux and hypopharyngeal cancer (Review).
Vageli DP, Doukas SG, Doukas PG, Judson BL. Vageli DP, et al. Oncol Rep. 2021 Nov;46(5):244. doi: 10.3892/or.2021.8195. Epub 2021 Sep 24. Oncol Rep. 2021. PMID: 34558652 Free PMC article. Review. - Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.
Li Y, Xu G, Zhou B, Tang Y, Liu X, Wu Y, Wang Y, Kong J, Xu T, He C, Zhu S, Wang X, Zhang J. Li Y, et al. Eur Arch Otorhinolaryngol. 2022 Jun;279(6):2743-2752. doi: 10.1007/s00405-021-07201-w. Epub 2021 Dec 3. Eur Arch Otorhinolaryngol. 2022. PMID: 34860271 Free PMC article. Review. - RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer.
Nakazato A, Mochizuki M, Shibuya-Takahashi R, Fujimori H, Fujii K, Saijoh S, Morita S, Yamazaki T, Imai T, Sato I, Satoh K, Yamaguchi K, Sugamura K, Yasuda J, Matsuura K, Shojaku H, Asada Y, Tamai K. Nakazato A, et al. Sci Rep. 2022 Oct 22;12(1):17751. doi: 10.1038/s41598-022-22736-6. Sci Rep. 2022. PMID: 36273237 Free PMC article. - The in vivo preventive and therapeutic properties of curcumin in bile reflux-related oncogenesis of the hypopharynx.
Doukas SG, Doukas PG, Sasaki CT, Vageli D. Doukas SG, et al. J Cell Mol Med. 2020 Sep;24(18):10311-10321. doi: 10.1111/jcmm.15640. Epub 2020 Jul 21. J Cell Mol Med. 2020. PMID: 32691972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous